Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

May heterocyclic γ-peptides provide polyfunctional platforms for synthetic glycocluster construction?

Simon M, Ali LMA, El Cheikh K, Aguesseau J, Gary-Bobo M, Garcia M, Morère A, Maillard LT.

Chemistry. 2018 May 30. doi: 10.1002/chem.201802032. [Epub ahead of print]

PMID:
29846978
2.

Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.

Basile I, Da Silva A, El Cheikh K, Godefroy A, Daurat M, Harmois A, Perez M, Caillaud C, Charbonné HV, Pau B, Gary-Bobo M, Morère A, Garcia M, Maynadier M.

J Control Release. 2018 Jan 10;269:15-23. doi: 10.1016/j.jconrel.2017.10.043. Epub 2017 Nov 3.

PMID:
29108866
3.

Stealth Biocompatible Si-Based Nanoparticles for Biomedical Applications.

Liu W, Chaix A, Gary-Bobo M, Angeletti B, Masion A, Da Silva A, Daurat M, Lichon L, Garcia M, Morère A, El Cheikh K, Durand JO, Cunin F, Auffan M.

Nanomaterials (Basel). 2017 Sep 23;7(10). pii: E288. doi: 10.3390/nano7100288.

4.

Porphyrins Conjugated with Peripheral Thiolato Gold(I) Complexes for Enhanced Photodynamic Therapy.

Longevial JF, El Cheikh K, Aggad D, Lebrun A, van der Lee A, Tielens F, Clément S, Morère A, Garcia M, Gary-Bobo M, Richeter S.

Chemistry. 2017 Oct 9;23(56):14017-14026. doi: 10.1002/chem.201702975. Epub 2017 Sep 8.

PMID:
28763126
5.

Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe Disease.

El Cheikh K, Basile I, Da Silva A, Bernon C, Cérutti P, Salgues F, Perez M, Maynadier M, Gary-Bobo M, Caillaud C, Cérutti M, Garcia M, Morère A.

Angew Chem Int Ed Engl. 2016 Nov 14;55(47):14774-14777. doi: 10.1002/anie.201607824. Epub 2016 Oct 24.

PMID:
27774736
6.

Why Anticancer Nanomedicine Needs Sugars?

Bouffard E, El Cheikh K, Gallud A, Da Silva A, Maynadier M, Basile I, Gary-Bobo M, Morere A, Garcia M.

Curr Med Chem. 2015;22(26):3014-24. Review.

PMID:
26242256
7.

Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.

Vaillant O, El Cheikh K, Warther D, Brevet D, Maynadier M, Bouffard E, Salgues F, Jeanjean A, Puche P, Mazerolles C, Maillard P, Mongin O, Blanchard-Desce M, Raehm L, Rébillard X, Durand JO, Gary-Bobo M, Morère A, Garcia M.

Angew Chem Int Ed Engl. 2015 May 11;54(20):5952-6. doi: 10.1002/anie.201500286. Epub 2015 Mar 20.

PMID:
25802144
8.

Two-photon excitation of porphyrin-functionalized porous silicon nanoparticles for photodynamic therapy.

Secret E, Maynadier M, Gallud A, Chaix A, Bouffard E, Gary-Bobo M, Marcotte N, Mongin O, El Cheikh K, Hugues V, Auffan M, Frochot C, Morère A, Maillard P, Blanchard-Desce M, Sailor MJ, Garcia M, Durand JO, Cunin F.

Adv Mater. 2014 Dec 3;26(45):7643-8. doi: 10.1002/adma.201403415. Epub 2014 Oct 17.

PMID:
25323443
9.

Targeting multiplicity: the key factor for anti-cancer nanoparticles.

Gary-Bobo M, Vaillant O, Maynadier M, Basile I, Gallud A, El Cheikh K, Bouffard E, Morère A, Rébillard X, Puche P, Nirdé P, Garcia M.

Curr Med Chem. 2013;20(15):1946-55. Review.

PMID:
23409718
10.

Low-molecular-weight heparin and mortality in acutely ill medical patients.

Kakkar AK, Cimminiello C, Goldhaber SZ, Parakh R, Wang C, Bergmann JF; LIFENOX Investigators.

N Engl J Med. 2011 Dec 29;365(26):2463-72. doi: 10.1056/NEJMoa1111288.

11.

Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.

Winum JY, Thiry A, Cheikh KE, Dogné JM, Montero JL, Vullo D, Scozzafava A, Masereel B, Supuran CT.

Bioorg Med Chem Lett. 2007 May 15;17(10):2685-91. Epub 2007 Mar 12.

PMID:
17376683
12.

Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.

Winum JY, Temperini C, El Cheikh K, Innocenti A, Vullo D, Ciattini S, Montero JL, Scozzafava A, Supuran CT.

J Med Chem. 2006 Nov 30;49(24):7024-31.

PMID:
17125255
13.

[A rare complication of antineoplastic BCG therapy: pulmonary tuberculosis].

Fenniche S, Hasséne H, Attia S, Fkih L, Bousnina S, Cheikh K, Belhabib D, Megdiche ML.

Tunis Med. 2001 Aug-Sep;79(8-9):467-70. French.

PMID:
11774792
14.

[Costal lysis caused by pulmonary histiocytosis X].

Fenniche S, Belhabib D, Cherif F, Cheikh K, Rabboubi C, Bousaina S, Labbéne N, Kilani T, Maalej M, Megdiche ML.

Tunis Med. 1998 Jan;76(1):1013-6. French. No abstract available.

PMID:
9577209

Supplemental Content

Loading ...
Support Center